Primary Site >> Esophagus Cancer
Gene >> SLC22A16
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: [The effect of hematoporphyrin photodynamic therapy on the growth of monoclonal cancer cells]. PMID: 1831730 |
Ref: Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. PMID: 12771883 |
Ref: [A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy]. PMID: 20037448 |
Ref: Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. PMID: 21503793 |
Ref: The value of (1)(8)F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy. PMID: 22660205 |
Ref: Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. PMID: 25212528 |
Ref: Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy. PMID: 26043837 Ref: Worldwide Esophageal Cancer Collaboration: clinical staging data. PMID: 27731549 |
Ref: Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials. PMID: 28815065 |
Ref: [Feasibility and preliminary technical experience of single incision plus one port laparoscopic total gastrectomy combined with pi-shaped esophagojejunal anastomosis in surgical treatment of gastric cancer]. PMID: 29774939 Ref: Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials. PMID: 29789277 Ref: Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma. PMID: 29950277 Ref: Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3. PMID: 30232909 |